Nuclear dna Measurements on Thyroid Carcinoma in Young Patients

References

• Cohn K, Bäckdahl M, Forsslund G, et al. Prognostic value of nuclear DNA content in papillary thyroid carcinoma. World J Surg 1984; 8: 474–80
   PubMed Web of Science ®Google Scholar
• Bäckdahl M, Tallroth E, Auer G, et al. Prognostic value of nuclear DNA content in medullary thyroid carcinoma. World J Surg 1985; 9: 980–7
   PubMed Web of Science ®Google Scholar
• Bäckdahl M, Auer G, Forsslund G, et al. Prognostic value of nuclear DNA content in follicular thyroid tumors. Acta Chir Scand 1986; 152: 1–7
   PubMedGoogle Scholar
• Tallroth E, Bäckdahl M, Einhorn J, Lundell G, Löwhagen T, Silfverswärd C. Thyroid carcinoma in children and adolescents. Cancer 1986; 58: 2329–32
   PubMed Web of Science ®Google Scholar
• Gaub J, Auer G, Zetterberg A. Quantitative cytochemical aspects of a combined Feulgen-Naphtol Yellow S staining procedure for the simultaneous determination of nuclear and cytoplasmic proteins and DNA in mammalian cells. Exp Cell Res 1975; 92: 323–32
   PubMed Web of Science ®Google Scholar
• Adams LR. A photographic cytophotometric method which avoids distributional error. Acta Cytol 1968; 12: 3–8
   PubMed Web of Science ®Google Scholar
• Caspersson T. Quantitative tumor cytochemistry—G.H.A. Clowes Memorial Lecture. Cancer Res 1979; 39: 2341–55
   PubMed Web of Science ®Google Scholar
• Caspersson T, Kudynowski J. Cytochemical instrumentation for cytopathological work. Int Rev Exp Pathol 1980; 21: 1–54
   Google Scholar
• Bäckdahl M, Carstensen J, Auer G, Tallroth E. Statistical evaluation of the prognostic value of nuclear DNA content in papillary, follicular and medullary thyroid tumors. World J Surg 1986; 10: 974–80
   PubMed Web of Science ®Google Scholar
• Schröder S, Böcker W, Baisch H, et al. Prognostic factors in medullary thyroid carcinomas. Survival in relation to age, sex, stage, histology, immunocytochemistry, and DNA content. Cancer 1988; 61: 806–16
   Google Scholar
• de Keyser L FM, van Herle AJ. Differentiated thyroid cancer in children. Head Neck Surg 1985; 8: 100–4
   Google Scholar
• Johannessen J V, Sobrinho-Simöes M, Tangen K O, Lindmo T. A flow cytometric deoxyribonucleic acid analysis of papillary thyroid carcinoma. Lab Invest 1981; 45: 336–41
   PubMed Web of Science ®Google Scholar
• Johannessen J V, Sobrinho-Simöes M, Lindmo T, Tangen KO. The diagnostic value of flow cytometric DNA measurements in selected disorders of the human thyroid. Am J Clin Pathol 1982; 77: 20–4
   PubMed Web of Science ®Google Scholar
• Tangen K O, Lindmo T, Sobrinho-Simöes M, Johannessen JV. A flow cytometric DNA analysis of medullary thyroid carcinoma. Am J Clin Pathol 1983; 79: 172–7
   PubMed Web of Science ®Google Scholar
• Greenebaum E, Koss L G, Elequin F, Silver CE. The diagnostic value of flow cytometric DNA measurements in follicular tumors of the thyroid gland. Cancer 1985; 56: 2011–8
   PubMed Web of Science ®Google Scholar
• Kraemer B B, Srigley J R, Batsakis J G, Silva E G, Goepfert H. DNA flow cytometry of thyroid neoplasms. Arch Otolaryngol 1985; 111: 34–8
   PubMedGoogle Scholar
• Christov K. Flow cytornetric DNA measurments in human thyroid tumors. Virchows Arch (B) 1986; 51: 255–63
   Google Scholar
• Joensuu H, Klemi P, Eerola E. DNA aneuploidy in follicular adenomas of the thyroid gland. Am J Pathol 1986; 124: 373–6
   PubMed Web of Science ®Google Scholar
• Joensuu H, Klemi P, Eerola E, Tuominen J. Influence of cellular DNA content on survival in differentiated thyroid cancer. Cancer 1986; 58: 2462–7
   PubMed Web of Science ®Google Scholar
• Rainwater L M, Farrow G M, Hay I D, Lieber MM. Oncocytic tumours of the salivary gland, kidney, and thyroid: nuclear DNA patterns studied by flow cytometry. Br J Cancer 1986; 53: 799–804
   PubMed Web of Science ®Google Scholar
• Mattfeldt T, Schürmann G, Feichter G. Stereology and flowcytometry of well-differentiated follicular neoplasms of the thyroid gland. Virchows Arch (A) 1987; 410: 433–41
   Web of Science ®Google Scholar
• Bengtsson A, Malmaeus J, Grimelius L, et al. Measurement of nuclear DNA content in thyroid diagnosis. World J Surg 1984; 8: 481–6
   PubMedGoogle Scholar
• Bondeson L, Azavedo E, Bondeson A-G, Caspersson T, Ljungberg O. Nuclear DNA content and behavior of oxyphil thyroid tumors. Cancer 1986; 58: 672–5
   Google Scholar
• Flint A, Davenport R D, Lloyd R V, Beckwith A L, Thompson NW. Cytophotometric measurements of Hürtle cell tumors of the thyroid gland. Correlation with pathologic features and clinical behavior. Cancer 1988; 61: 110–3
   PubMed Web of Science ®Google Scholar
• Hedley D W, Rugg C A, Ng A BP, Taylor IW. Influence of cellular DNA content on disease-free survival of stage II breast cancer patients. Cancer Res 1984; 44: 5395–8
   PubMed Web of Science ®Google Scholar
• van Driel-Kulker A MJ, Mesker W E, van der Burg M JM, Ploems JS. Preparation of cells from paraffin-embedded tissue for cytometry and cytomorphologic evaluation. Anal Quant Cytol Histol 1987; 9: 225–31
   Google Scholar
• Auer G U, Askensten U, Erhardt K, Fallenius A, Zetterberg A. Comparison between slide and flow cytophotometric DNA measurements in breast tumors. Anal Quant Cytol Histol 1987; 9: 138–46
   PubMedGoogle Scholar
• Fallenius A G, Askensten U G, Skoog L K, Auer GU. The reliability of microspectrophotometric and flow cytometric nuclear DNA measurements in adenocarcinomas of the breast. Cytometry 1987; 8: 260–6
   PubMedGoogle Scholar
• Auer G U, Böckdahl M, Forsslund G M, Askensten UG. Ploidy levels in nonneoplastic and neoplastic thyroid cells. Anal Quant Cytol Histol 1985; 7: 97–106
   Google Scholar